New trial aims to solve the mystery of cancers with unknown origins

NCT ID NCT07366008

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is for people with Cancer of Unknown Primary (CUP), where doctors can't find where the cancer started. The goal is to use advanced genetic tests on tumor samples to identify the cancer's origin. This information may help doctors choose more effective treatments and improve survival. About 350 participants will provide biopsies, blood, and stool samples for analysis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF UNKNOWN PRIMARY SITE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer of unknown primary site Neoplasms, Unknown Primary

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akershus University Hospital

    Oslo, Norway

    Contact Email: •••••@•••••

  • Haukeland University Hospital

    Bergen, 5021, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Oslo University Hospital

    Oslo, Norway

    Contact Email: •••••@•••••

  • St Olavs Hospital

    Trondheim, Norway

    Contact Email: •••••@•••••

  • Stavanger University Hospital

    Stavanger, Norway

    Contact Email: •••••@•••••

  • University Hospital of North-Norway

    Tromsø, Norway

    Contact Email: •••••@•••••